Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FSQS5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,442
Award facts
- Contract value 100% obligated
- $25,441.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,441.84 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 5 mg on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order carries no set-aside designation, indicating the award was made through unrestricted competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the awardee based on its established capabilities as a critical supplier within the federal pharmaceutical supply chain. The contract place of performance is located in Park Ridge, IL 60068.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499.999 billion and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. This contracting vehicle enables the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The current delivery order for Jakafi represents one of numerous orders issued under this framework to maintain critical pharmaceutical inventory for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FSQS5?
SPE2DR26FSQS5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FSQS5 worth?
The government has obligated $25,442 on SPE2DR26FSQS5.
Is contract SPE2DR26FSQS5 an order under another contract?
Yes. SPE2DR26FSQS5 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQS5 competed?
The extent of competition for SPE2DR26FSQS5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award